Skip to main content
Live · TradingView
Back to the NewsWire

Markets Businessinsider

Published September 16, 2026 · Updated September 17, 2026

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted ...

Read the full story at Markets Businessinsider

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder. PRESS RELEASE.

Surfaced by 4 Google Alerts

  • Psychedelic press release
  • Psychedelic crime
  • Psychedelic biotech
  • MDMA